BANGKOK, Thailand, Aug. 16, 2023 – Edan Instruments, Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its innovative range of laboratory equipment at the Medlab Asia & Asia Health 2023 in Thailand. This ASEAN region’s leading exhibition is expected to gather more than 4,000 attendees interested in diagnostic technologies and innovative solutions within the healthcare industry.
At the heart of EDAN's showcase was its pioneering laboratory solutions, which drew considerable attention from attendees, including the first molecular diagnostics analysis system, ClariLight CL30, and the CO-oximetry blood gas and chemistry system, i20, which were both newly launched last year. As for the In-Vitro Diagnostics sector, the 5-part auto hematology analyzer, H60S, also captured the spotlight. The laboratory innovations presented are poised to redefine diagnostics and research capabilities, contributing to enhanced patient care and scientific advancements.
EDAN seized the opportunity to engage with partners, clients, and industry professionals, fostering meaningful connections that pave the way for future collaborations. The interactions with attendees were characterized by vibrant discussions and idea exchange, reaffirming EDAN's role as a leading player in the industry.
The backdrop of Bangkok, renowned for its warm hospitality and progressive healthcare perspective, adds to the anticipation surrounding this event. Against this backdrop, Medlab Asia & Asia Health 2023 is poised to emerge as a significant juncture, providing EDAN with the ideal canvas to leave an indelible mark on the laboratory sector. The event serves as an invaluable avenue for EDAN to contribute actively to the evolution of healthcare solutions within the region.
For further information, please visit www.edan.com.
